|
|
Links
Home |
AprotininThis page contains recent news articles, when available, and an overview of AprotininRecent news articles mentioning AprotininCostly bypass medication may raise death risk later - Feb 20, 2007 Asbury Park Press, More than 4 million patients worldwide have received aprotinin, sold as Trasylol, since 1985, the scientists write in the Journal of the American Medical Aprotinin May Lead to Fatal Blood Clots - Feb 13, 2007 KTEN, One such drug, aprotinin, may lead to fatal blood clots in CABG patients, that's according to a new study in the journal of the American Medical Association CABG patients on Aprotinin more likely to die - Feb 7, 2007 Food Consumer, Those who underwent cardiac surgery and took aprotinin, an anti-bleeding drug are at a significantly higher risk of death compared to those who received the Lakeland, Haven Hospitals Don't Use Anti-Bleeding Drug Aprotinin - Feb 9, 2007 The Ledger, Aprotinin, also called Trasylol, is one of several drugs that can be used to prevent excessive bleeding during open-heart surgery. Aprotinin use associated with an increased risk of death following ... - Feb 7, 2007 News-Medical.net, Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years Aprotinin increases long-term mortality in new analysis - Feb 6, 2007 TheHeart.Org, San Bruno, CA - Concerns over the safety of aprotinin (Trasylol, Bayer) will be fueled by a new analysis published this week suggesting that the drug, Aprotinin—Are There Lessons Learned? - Feb 6, 2007 Journal of American Medical Association (subscription), This past year has been a complicated one for aprotinin, an antifibrinolytic serine protease inhibitor used to lessen bleeding in patients undergoing Aprotinin, drug used in cardiac surgery, heightens death risk: study - Feb 6, 2007 France24, According to a new study published in the February 7 issue of the Journal of the American Medical Association, the drug, aprotinin, was used on more than Study raises concerns about heart surgery drug - Feb 13, 2007 Sauk Valley Newspapers, The researchers said replacing the drug - aprotinin, sold by Bayer AG under the brand name Trasylol - with other, cheaper medications for a year would Bayer Discontinues Trasylol® (Aprotinin Injection) Clinical Trial ... - Jan 25, 2007 DG News 2007 -- Bayer HealthCare has decided to end three ongoing clinical studies investigating the safety and efficacy of Trasylol® (aprotinin injection) on Cardiac surgeons unfazed by drug findings - Feb 17, 2007 Therapeutics Daily (subscription) (press release), A ten-year study recently found that 3876 patients from 16 countries who use aprotinin, sold under the brand name Trasylol by Bayer AG, while undergoing Bypass Drug Linked To Spike In Deaths - Feb 7, 2007 CBS News, ...(WebMD) A new study questions the continued use of the drug aprotinin, commonly used to limit blood loss during some types of cardiac surgery, due to safety Bayer’s Heart-Surgery Drug Increases Risk of Death - Feb 7, 2007 Newsinferno.com, Bayer’s controversial heart-surgery drug aprotinin, marketed as Trasylol, is under fire yet again thanks to a new study that found that the drug carries Drug Used in Coronary Artery Bypass Graft Surgery May Increase ... - Feb 7, 2007 DG News Aprotinin was first approved for use in high-risk patients needing coronary artery surgery in the United States in 1993. As background information in the Heart Surgery Drug May Boost Death Risk - Feb 6, 2007 Forbes, 6 (HealthDay News) -- Patients given aprotinin, a drug used to limit blood loss in heart bypass surgery, are at greater risk of dying over the next five Study: heart surgery drug increases death risk - Feb 7, 2007 Xinhua, 7 (Xinhuanet) -- A recent international study has found aprotinin -- a drug sold by Bayer AG under the brand name Trasylol -- used to avoid excessive Heart Surgery Drug Linked To Death Risk - Feb 7, 2007 Today's THV, The researchers said replacing the drug, aprotinin, sold by Bayer AG under the brand name Trasylol, with other, cheaper medications for a year would prevent Drug Used in Coronary Artery Bypass Graft Surgery May Increase ... - Feb 6, 2007 Newswise (press release) Newswise — Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five Heart surgery drug may turn deadly: study - Feb 6, 2007 Globe and Mail, The researchers said replacing the drug — aprotinin, sold by Bayer AG under the brand name Trasylol — with other, cheaper medications for a year would Heart Surgery Drug Linked to Death Risk - Feb 6, 2007 Salon The researchers said replacing the drug -- aprotinin, sold by Bayer AG under the brand name Trasylol -- with other, cheaper medications for a year would Heart Surgery Drug Linked to Death Risk - Feb 6, 2007 CBS News, The researchers said replacing the drug _ aprotinin, sold by Bayer AG under the brand name Trasylol _ with other, cheaper medications for a year would Safety of Heart-Surgery Drug Questioned - Feb 6, 2007 Forbes, The FDA is already reviewing aprotinin's safety. The new study is an important contribution to that review, which could result in additional warnings, Surgery drug risky, study says - Feb 6, 2007 Northwest Herald, The researchers said replacing the drug – aprotinin, sold by Bayer AG under the brand name Trasylol – with other, cheaper medications for a year would Heart surgery drug linked to death risk - Feb 6, 2007 Denver Post, The researchers said replacing the drug—aprotinin, sold by Bayer AG under the brand name Trasylol—with other, cheaper medications for a year would prevent Anti-bleeding Drug Increases Death Risk Following Heart Surgery - Feb 7, 2007 Medical News Today, A US study raises fresh concerns about the anti-bleeding drug aprotinin which is presecribed to patients following cardiac surgery. Heart surgery drug linked to death risk - Feb 7, 2007 Meadow Free Press, The FDA is already reviewing aprotinin‘s safety. The new study is an important contribution to that review, which could result in additional warnings, Concerns raised on bleeding drug - Feb 7, 2007 Boston Globe, The researchers said replacing the drug -- aprotinin, sold by Bayer AG under the brand name Trasylol -- with other, less expensive medications for a year Surgery drug worries doctors - Feb 7, 2007 Miami Herald, A study said that the heart-surgery drug aprotinin, also called Trasylol, apparently increases the risk of dying by almost 50 percent in the five years Drug increases risk, study says - Feb 6, 2007 Winston-Salem Journal (subscription), The researchers said that replacing the drug - aprotinin, sold by Bayer AG under the brand name Trasylol - with other, cheaper medications for a year would Other uses for Aprotinin [MedMaster Patient Drug Information database] Before taking rasagiline,
|